Early cancer detection via blood screening, by Illumina

get it
#4 Product of the DayJanuary 11, 2016

GRAIL's mission is to detect cancer early, when it can be cured.



MakersThere are no makers yet
You need to become a Contributor to join the discussion - Find out how.
I think its GRAIL and not GARIL
Kumar Thangudu@datarade · Technologist
This one should really be at the top of ProductHunt.
Garrett Flanagan@flanaganlyfe · President, CredentialedCARE
Great article on Grail in MIT Technology Review -
Edwin Espinosa@edwinespinosa09 · Angularjobs
@flanaganlyfe great article thanks! One of the major problems historically is that the DNA mutations that are released are very trace, I've heard the analogy "needle in the haystack" more than once. Hopefully they can make their test something routine like a paps exam, now if we could get insurance on board :(
Garrett Flanagan@flanaganlyfe · President, CredentialedCARE
@edwinespinosa09 I'm bullish, Illumina has the tech to succeed and scale where (many) others have failed.
A very good initiative. But what matters most is what will be the pricing for a single test. If it ends up being priced like the BRCA1 and BRCA2 gene mutations test then point is lost. One other thought is the psychological impact of such a test. There is a very good possibility that most people who takes this test might end up being positive for some sort of cancer. Although you might not have contracted cancer you might end being treating yourself like one, right?
Emmanuel AmberberHunter@emmanuelamber · Data & Product Head | @YSProfiles
"At least half of all cancers in the United States are diagnosed in Stage III and Stage IV, leading to lower survival rates. Detecting cancer at the earliest stages dramatically increases the probability of a cure and long-term survival." - Huge potential here. I believe GRAIL is poised for rapid global scale. It imposes no limitation to how many times a person can go for screening as their screening is free from radiation exposures and invasive procedures. Good luck.